Hims & Hers Health (NYSE:HIMS) Trading Down 0% - What's Next?

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report)'s stock price was down 0% on Wednesday . The stock traded as low as $60.26 and last traded at $61.20. Approximately 12,962,684 shares traded hands during trading, a decline of 33% from the average daily volume of 19,301,928 shares. The stock had previously closed at $61.21.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Morgan Stanley cut their price target on shares of Hims & Hers Health from $60.00 to $40.00 and set an "equal weight" rating for the company in a report on Tuesday, April 29th. Piper Sandler restated a "neutral" rating and set a $39.00 price objective (up from $35.00) on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Needham & Company LLC reaffirmed a "buy" rating and set a $61.00 target price on shares of Hims & Hers Health in a research note on Tuesday, May 6th. Citigroup reaffirmed a "sell" rating and set a $30.00 target price (up previously from $25.00) on shares of Hims & Hers Health in a research note on Tuesday, May 6th. Finally, Leerink Partners raised their price objective on shares of Hims & Hers Health from $24.00 to $40.00 and gave the company a "market perform" rating in a research note on Tuesday, February 25th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $37.67.

Hims & Hers Health Stock Down 3.2%

The firm has a market capitalization of $13.26 billion, a P/E ratio of 136.68 and a beta of 1.84. The business's 50 day moving average is $36.60 and its two-hundred day moving average is $34.38.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The company had revenue of $586.01 million during the quarter, compared to analyst estimates of $535.21 million. During the same quarter last year, the firm posted $0.05 EPS. The business's revenue for the quarter was up 110.7% on a year-over-year basis. As a group, equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Michael Chi sold 17,303 shares of Hims & Hers Health stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $48.14, for a total value of $832,966.42. Following the transaction, the insider now owns 193,601 shares of the company's stock, valued at approximately $9,319,952.14. This trade represents a 8.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Patrick Harrison Carroll sold 23,287 shares of Hims & Hers Health stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $34.31, for a total value of $798,976.97. Following the completion of the transaction, the insider now directly owns 209,661 shares in the company, valued at $7,193,468.91. This represents a 10.00% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 618,936 shares of company stock valued at $25,182,692. 13.71% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Hims & Hers Health

Several institutional investors and hedge funds have recently bought and sold shares of HIMS. Barclays PLC grew its stake in Hims & Hers Health by 9.7% during the 3rd quarter. Barclays PLC now owns 308,363 shares of the company's stock valued at $5,680,000 after acquiring an additional 27,231 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Hims & Hers Health by 115.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 4,560 shares of the company's stock valued at $110,000 after buying an additional 2,442 shares in the last quarter. SG Americas Securities LLC grew its stake in shares of Hims & Hers Health by 44.0% in the 4th quarter. SG Americas Securities LLC now owns 104,422 shares of the company's stock valued at $2,525,000 after buying an additional 31,915 shares in the last quarter. Raleigh Capital Management Inc. grew its stake in shares of Hims & Hers Health by 1,100.0% in the 4th quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company's stock valued at $29,000 after buying an additional 1,100 shares in the last quarter. Finally, KBC Group NV grew its stake in shares of Hims & Hers Health by 107.9% in the 4th quarter. KBC Group NV now owns 8,471 shares of the company's stock valued at $205,000 after buying an additional 4,396 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company's stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.